Ypsomed Holding AG
Research Ypsomed Holding AG (OWX) on Bullrun: market cap EUR 5.70B, P/E 24.9, dividend yield 1.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOWX
- ExchangeF
- CountrySwitzerland
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyEUR
- Market capEUR 5.70B
- P/E24.9
- Dividend yield1.1%
- Financial periodFY2026
- RevenueCHF 730.98M
- Revenue growth-2.4%
- Net incomeCHF 221.93M
- Free cash flow-CHF 16.34M
- Gross margin43.0%
Valuation Snapshot
latest market cap is EUR 5.70B; P/E is 24.9; dividend yield is 1.1%.
Peer valuation comparison
Latest P/E is 24.91x versus a Healthcare sector median of 24.46x.
Latest dividend yield is 1.11% versus a Healthcare sector median of 2.11% (47.4% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | CHF 730.98M | CHF 221.93M | -CHF 16.34M | 43.0% | 16.3 | CHF 28.56M | CHF 260.77M | CHF 748.13M |
| FY2025 | CHF 748.87M | CHF 87.50M | -CHF 128.95M | 39.0% | 6.41 | CHF 36.50M | CHF 267.00M | CHF 679.69M |
| FY2024 | CHF 548.46M | CHF 78.37M | -CHF 32.09M | 40.0% | 5.74 | CHF 74.02M | CHF 256.00M | CHF 617.73M |
| FY2023 | CHF 497.46M | CHF 51.28M | -CHF 39.64M | 28.3% | 3.82 | CHF 25.22M | CHF 157.00M | CHF 562.33M |
| FY2022 | CHF 464.84M | CHF 23.11M | -CHF 41.72M | 24.5% | 1.83 | CHF 17.04M | CHF 267.00M | CHF 392.54M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 5.70B | 24.9 | 1.1% | 4.77 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 4.77 EUR, yield 1.1%.
| Year | Dividends/share |
|---|---|
| FY2026 | 4.71 CHF |
| FY2025 | 2.39 CHF |
| FY2023 | 2.12 CHF |
| FY2022 | 0.65 CHF |
About Ypsomed Holding AG
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoirs.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Ypsomed Holding AG's market cap?
Ypsomed Holding AG's market capitalization is EUR 5.70B.
What is Ypsomed Holding AG's P/E ratio?
Ypsomed Holding AG's price-to-earnings (P/E) ratio is 24.9.
Does Ypsomed Holding AG pay a dividend?
Ypsomed Holding AG has a dividend yield of 1.1%.
What does Ypsomed Holding AG do?
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoirs. The company markets its products to hospitals, doctors, pharmacies and patients via subsidiaries and distributors.